A prospective randomized comparison of stranded vs. loose 125I seeds for prostate brachytherapy

Brachytherapy

Volumn 6, Issue 2, 2007, Pages 129-134

  Reed, Daniel R ^a,b,c   Wallner, Kent E ^b,c,d   Merrick, Gregory S ^e   Arthurs, Sandra ^c   Mueller, Amy ^c   Cavanagh, William ^c   Butler, Wayner B ^e   Ford, Eric ^b,c   Sutlief, Steve G ^b,c  

^a Arizona Oncology Services   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

^e WHEELING HOSPITAL   (United States)

Author keywords

Brachytherapy; Dosimetry; Prostate; Seeds

Indexed keywords

IODINE 125;

ARTICLE; BRACHYTHERAPY; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CARCINOMA; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING;

ALGORITHMS; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; RADIOMETRY; RECTUM; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR BURDEN; WASHINGTON;

EID: 34047272138     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2007.01.003     Document Type: Article

References (31)

1. Potters L., Cao Y., Calugaru E., et al. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 50 (2001) 605-614
2. Stock R.G., Stone N.N., Dahlal M., et al. What is the optimal dose for 125-I prostate implant? A dose-response analysis of biochemical control, posttreatment prostate biopsies, and long-term symptoms. Brachytherapy 1 (2002) 83-89
3. Wallner K., Merrick G., True L., et al. I-125 versus Pd-103 for low risk prostate cancer: Preliminary biochemical outcomes from a prospective randomized multicenter trial. Int J Radiat Oncol Biol Phys 57 (2003) 1297-1303
4. Choi S., Wallner K.E., Merrick G., et al. Treatment margins predict biochemical outcomes after prostate brachytherapy. Cancer J 10 (2004) 175-180
5. Nedea E., Wallner K., Reed D., et al. Extra-prostatic seed placement and its effect on seed loss. Cancer J 11 (2005) 147-151
6. Al-Qaisieh B., Carey B., Ash D., et al. The use of linked seeds eliminates lung embolization following permanent seed implantation for prostate cancer. Int J Radiat Oncol Biol Phys 59 (2004) 1063-1067
7. Tapen E.M., Blasko J.C., Grimm P.D., et al. Reduction of radioactive seed embolization to the lung following prostate brachytherapy. Int J Radiat Oncol Biol Phys 42 (1998) 1063-1067
8. Kunos C., Resnick M., Kinsella T., et al. Migration of implanted free radioactive seeds for adenocarcinoma of the prostate using a Mick applicator. Brachytherapy 3 (2004) 71-77
9. Blair H., Porter A., and Chen Q.-S. In vivo detection of an 125-I seed located in the intracardiac region after prostate permanent brachytherapy. Int J Radiat Oncol Biol Phys 58 (2004) 888-891
10. Sommerkamp H., Rupprecht M., and Wannenmacher M. Seed loss in interstitial radiotherapy of prostatic carcinoma with I-125. Int J Radiat Oncol Biol Phys 14 (1988) 389-392
11. Stutz M., Petrikas J., Raslowsky M., et al. Seed loss through the urinary tract after prostate brachytherapy: examining the role of cystoscopy and urine straining post implant. Med Phys 30 (2003) 2695-2698
12. Dafoe-Lambie J., Abel L., Blatt H., et al. Radioactive seed embolization to the lung following prostate brachytherapy. W V Med J 96 (2000) 357-360
13. Nag S., Vivekanandam S., and Martinez-Monge R. Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 39 (1997) 667-670
14. Steinfeld A.D., Donahue B.R., and Plaine L. Pulmonary embolization of iodine-125 seeds following prostate implantation. Urology 37 (1991) 149-150
15. Davis B.J., Pfeifer E.A., Wilson T.M., et al. Prostate brachytherapy seed migration to the right ventricle found at autopsy following acute cardiac dysrhythmia. J Urol 164 (2000) 1661
16. Davis B., Bresnahan J., Stafford S., et al. Prostate brachytherapy seed migration to a coronary artery found during angiography. J Urol 168 (2002) 1103
17. Ankem M., DeCarvalho V., Harangozo A., et al. Implications of radioactive seed migration to the lungs after prostate brachytherapy. Urology 59 (2002) 555-559
18. Eshleman J., Davis B., Pisansky T., et al. Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: extraprostatic seed placement correlates with migration. Int J Radiat Oncol Biol Phys 59 (2004) 419-425
19. Kaplan I., Meskell P., Lieberfarb M., et al. A comparison of the precision of seeds deposited as loose seeds versus suture embedded seeds: A randomized trial. Brachytherapy 3 (2004) 7-9
20. Fuller D., Koziol J., and Feng A. Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors. Brachytherapy 2004 (2004) 10-19
21. Fagundes H., Keys R., Wojcik M., et al. Transperineal TRUS-guided prostate brachytherapy using loose seeds versus RAPIDStrand: A dosimetric analysis. Brachytherapy 3 (2004) 136-140
22. Lee R., deGuzman A.F., Tomlinson S., et al. Radioactive sources embedded in suture are associated with improved post-implant dosimetry in men treated with prostate brachytherapy. Radiother Oncol 65 (2002) 123-127
23. Merrick G.S., and Butler W.M. Modified uniform seed loading for prostate brachytherapy: rationale, design, and evaluation. Tech Urol 6 (2000) 78-84
24. Mueller A., Wallner K., Merrick G., et al. Perirectal seeds as a risk factor for prostate brachytherapy-related rectal bleeding. Int J Radiat Oncol Biol Phys 59 (2004) 1047-1052
25. Merrick G.S., Butler W.M., Dorsey A.T., et al. The dependence of prostate postimplant dosimetric quality on CT volume determination. Int J Radiat Oncol Biol Phys 44 (1999) 1111-1117
26. McLaughlin P., Narayana V., Pan C., et al. Comparison of day 0 and day 14 dosimetry for permanent prostate implant using stranded seeds. Int J Radiat Oncol Biol Phys 64 (2005) 144-150
27. Taussky D., Yeung I., Williams T., et al. Rectal-wall dose dependence on postplan timing after permanent-seed prostate brachytherapy. Int J Radiat Oncol Biol Phys 65 (2006) 358-363
28. Butzbach D., Waterman F.M., and Dicker A.P. Can extraprostatic extension be treated by prostate brachytherapy? An analysis based on postimplant dosimetry. Int J Radiat Oncol Biol Phys 51 (2001) 1196-1199
29. Merrick G.S., Butler W.M., Wallner K.E., et al. Extracapsular dose distribution following permanent prostate brachytherapy. Am J Clin Oncol 26 (2003) 178-189
30. Reed D., Wallner K., Ford E., et al. Effect of post-implant edema on prostate brachytherapy treatment margins. Int J Radiat Oncol Biol Phys 63 (2005) 1469-1473
31. Wallner K., Merrick G., Blasko J., et al. Prostate brachytherapy made complicated. 3rd ed. (2007), SmartMedicine Press, Seattle